Embracing the Change: 2020 China NRDL Outlook
China’s 2020 NRDL (National Reimbursement Drug List) process has been unfolding since July this year with a number of new changes and interesting twists.
| Blog | Healthcare & Life Sciences Pharma & Biotechnology Commercial Strategy & Pricing Consulting